IIQ 4.21% 49.5¢ inoviq ltd

Ann: Progress on Assay Development Program, page-77

  1. 522 Posts.
    lightbulb Created with Sketch. 57
    The fact that the kit has progressed makes me happy with what's going on. It could've been announced a bit more timely and reeks of being held back from the market for a while. I have chipped in my share to the Co. and fully taken up my NRRI.

    It appears by the announcement and previous announcements the kits were being and therefore are already developed to work on Luminex. They are developed for RUO (Research Use Only). All they need to do is sign an agreement on price with TF for "Commercial Use". I'm sure they are already working out the numbers.

    "The RUO kit is a 22-plex Peptide Marker Panel for Detection of Human Antibodies for BARD1. Commercial development of the BARD1 autoantibody tests will require an agreement with Luminex for commercial use rights"
    The kits were deliberately also developed to be easily applicable to multiple caners including the breat then the lung, then the others. Time to sit back. Ping me in a few months, I read IT. I can't stand clowns.

 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.